Drugs / Umbilical Cord-Derived Mesenchymal Stem Cells
Umbilical Cord-Derived Mesenchymal Stem Cells
Trials 10
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT07011199 | Jun 2025 → Apr 2026 overdue | biliary atresia, fibrotic liver disease | Universitas Diponegoro | Not yet recruiting | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT05794425 | Aug 2023 → Apr 2025 | bone marrow failure syndrome | Shandong Qilu Stem Cells Engineering Co., Ltd. | Unknown | No outcome recorded |
| Phase 1/2 | NCT05672420 | Jan → Dec 2023 | anemia, hematopoietic and lymphoid cell neoplasm, hemorrhagic disease, infectious disease +2 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Unknown | No outcome recorded |
| Phase 1/2 | NCT01547091 | Apr 2013 → Oct 2014 | rheumatoid arthritis | Alliancells Bioscience Corporation Limited | Unknown | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT04811651 | Mar 2021 → Jul 2024 | ischemic stroke | General Hospital of Shenyang Military Region | Completed | No outcome recorded |
| Phase 2 | NCT04429763 | Jul → Sep 2020 | COVID-19 | Trustem | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT07480161 | Dec 2025 → Dec 2027 expected | erectile dysfunction | Ankara City Hospital Bilkent | Recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05939817 | Oct 2021 → Jun 2022 | keloid | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Completed | No outcome recorded |
| Phase 4 | NCT05887804 | Oct 2021 → Jun 2022 | keloid | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03608592 | Jun 2018 → Aug 2020 | adult acute respiratory distress syndrome | Sun Yat-sen University | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT03326505 Comparator | Sep 2017 → Jan 2020 | multiple sclerosis | University of Jordan | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2024-03-04 | CytoMed Therapeutics Pte Ltd | CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair cytomed.sg ↗ |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | umbilical cord-derived mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05887804 ↗ |
| Known as | UC-MSC | “umbilical cord-derived mesenchymal stem cells (UC-MSC)” NCT05939817 ↗1“umbilical cord-derived mesenchymal stem cells (UC-MSC)” NCT05887804 ↗ |
| Known as | UC-MSCs | “umbilical cord derived mesenchymal stem cells (UCMSCs) suspension” NCT03608592 ↗3“Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)” NCT01547091 ↗ “Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)” NCT07011199 ↗ “umbilical cord derived mesenchymal stem cells (UC-MSCs)” NCT05672420 ↗ |
| Known as | WJ-MSCs | “The purpose of this study is to explore the effect of combining physical therapy exercises (PTE) and Wharton Jelly mesenchymal stem cell (WJ-MSCs) injections on motor and...” PMID 32846775 ↗ Aug 2020 |
| Modality | Cell therapy | “mesenchymal stem cell therapy” PMID 32846775 ↗ Aug 2020 |
| Route | Intravenous | “The UC-MSCs will be infused intravenously” NCT01547091 ↗ |